Phosphorus-31 two-dimensional chemical shift imaging in the myocardium of patients with late onset of Friedreich ataxia

Molecular Imaging and Biology

Volumn 10, Issue 1, 2008, Pages 24-29

  Wolf, Christian ^a   Boesch, Sylvia ^a   Metzler, Bernhard ^b   Weirich Schwaiger, Helga ^a   Trieb, Thomas ^a   Schocke, Michael F H ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Cardiac 31P 2D CSI; Friedreich ataxia; Mitochondrial function; Myocardial hypertrophy

Indexed keywords

ADENINE; ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; FRATAXIN; GUANINE; PHOSPHATE; PHOSPHORUS 31;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; ECHOCARDIOGRAPHY; FEMALE; FRIEDREICH ATAXIA; HEART EJECTION FRACTION; HEART FUNCTION; HEART MUSCLE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE SEPTUM; HUMAN; IMAGE PROCESSING; INTRON; MALE; MITOCHONDRION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR OVERHAUSER EFFECT; PATHOGENESIS; PHOSPHATE METABOLISM; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; THICKNESS; TRINUCLEOTIDE REPEAT;

ADENOSINE TRIPHOSPHATE; ADULT; AGE OF ONSET; DEMOGRAPHY; FEMALE; FRIEDREICH ATAXIA; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIUM; PHOSPHOCREATINE; PHOSPHORUS ISOTOPES;

EID: 37849019347     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-007-0119-y     Document Type: Article

References (27)

1. Voncken M, Ioannou P, Delatycki MB (2004) Friedreich ataxia - update on pathogenesis and possible therapies. Neurogenetics 5:1-8
2. Chamberlain S, Shaw J, Rowland A et al (1988) Mapping of mutation causing Friedreich's ataxia to human chromosome 9. Nature 334:248-250
3. Lodi R, Rajagopalan B, Blamire AM et al (2001) Cardiac energetics are abnormal in Friedreich ataxia patients in the absence of cardiac dysfunction and hypertrophy: An in vivo 31P magnetic resonance spectroscopy study. Cardiovasc Res 52:111-119
4. Puccio H, Simon D, Cossee M et al (2001) Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet 27:181-186
5. De Michele G, Perrone F, Filla A et al (1996) Age of onset, sex, and cardiomyopathy as predictors of disability and survival in Friedreich's disease: A retrospective study on 119 patients. Neurology 47:1260-1264
6. Vorgerd M, Schols L, Hardt C, Ristow M, Epplen JT, Zange J (2000) Mitochondrial impairment of human muscle in Friedreich ataxia in vivo. Neuromuscul Disord 10:430-435
7. Bradley JL, Blake JC, Chamberlain S, Thomas PK, Cooper JM, Schapira AH (2000) Clinical, biochemical, and molecular genetic correlations in Friedreich's ataxia. Hum Mol Genet 9:275-282
8. Al Mahdawi S, Pinto RM, Varshney D et al (2006) GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology. Genomics 88:580-590
9. Bunse M, Bit-Avragim N, Riefflin A et al (2003) Cardiac energetics correlates to myocardial hypertrophy in Friedreich's ataxia. Ann Neurol 53:121-123
10. Campuzano V, Montermini L, Molto MD et al (1996) Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271:1423-1427
11. Vikhoff-Baaz B, Starck G, Ljungberg M, Lagerstrand K, Forssell-Aronsson E, Ekholm S (2001) Effects of k-space filtering and image interpolation on image fidelity in (1)H MRSI. Magn Reson Imaging 19:1227-1234
12. Van Dobbenburgh JO, Lekkerkerk C, Van Echteld CJ, de Beer R (1994) Saturation correction in human cardiac 31P MR spectroscopy at 1.5 T. NMR Biomed 7:218-224
13. Freeman DM, Hurd R (1997) Decoupling: Theory and practice II. State of the art: In vivo applications of decoupling. NMR Biomed 10:381-393
14. Gabr RE, Ouwerkerk R, Bottomley PA (2006) Quantifying in vivo MR spectra with circles. J Magn Reson 179:152-163
15. McKenna WJ, Spirito P, Desnos M, Dubourg O, Komajda M (1997) Experience from clinical genetics in hypertrophic cardiomyopathy: Proposal for new diagnostic criteria in adult members of affected families. Heart 77:130-132
16. Schocke MFH, Metzler B, Wolf C et al (2003) Impact of aging on cardiac high-energy phosphate metabolism determined by phosphorus-31 2-dimensional chemical shift imaging (31P 2D CSI). Magn Reson Imaging 21:553-559
17. Karthikeyan G, Santos JH, Graziewicz MA et al (2003) Reduction in frataxin causes progressive accumulation of mitochondrial damage. Hum Mol Genet 12:3331-3342
18. Durr A, Cossee M, Agid Y et al (1996) Clinical and genetic abnormalities in patients with Friedreich's ataxia. N Engl J Med 335:1169-1175
19. Bit-Avragim N, Perrot A, Schols L et al (2001) The GAA repeat expansion in intron 1 of the frataxin gene is related to the severity of cardiac manifestation in patients with Friedreich's ataxia. J Mol. Med 78:626-632
20. Lodi R, Rajagopalan B, Blamire AM, Crilley JG, Styles P, Chinnery PF (2004) Abnormal cardiac energetics in patients carrying the A3243G mtDNA mutation measured in vivo using phosphorus MR spectroscopy. Biochim Biophys Acta 1657:146-150
21. Schocke MFH, Zoller H, Vogel W et al (2004) Cardiac phosphorus-31 two-dimensional chemical shift imaging in patients with hereditary hemochromatosis. Magn Reson Imaging 22:515-521
22. Crilley JG, Boehm EA, Rajagopalan B et al (2000) Magnetic resonance spectroscopy evidence of abnormal cardiac energetics in Xp21 muscular dystrophy. J Am Coll Cardiol 36:1953-1958
23. Gregory SA, MacRae CA, Aziz K et al (2007) Myocardial blood flow and oxygen consumption in patients with Friedreich's ataxia prior to the onset of cardiomyopathy. Coron Artery Dis 18:15-22
24. Gakh O, Park S, Liu G et al (2006) Mitochondrial iron detoxification is a primary function of frataxin that limits oxidative damage and preserves cell longevity. Hum Mol Genet 15:467-479
25. Greiner A, Esterhammer R, Messner H et al (2006) High-energy phosphate metabolism during incremental calf exercise in patients with unilaterally symptomatic peripheral arterial disease measured by phosphor 31 magnetic resonance spectroscopy. J Vasc Surg 43:978-986
26. Schocke MFH, Esterhammer R, Ostermann S et al (2006) High-energy phosphate metabolism during calf ergometry in patients with isolated aorto-iliac artery stenoses. Invest Radiol 41:874-882
27. Klug G, Zwick R, Frick M et al (2007) Impact of exercise capacity on myocardial high-energy phosphate metabolism. Int J Sports Med 28:667-672